Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | PPARG | P37231 | 6/20 | 0.43 |
| ▸ | PPARD | Q03181 | 6/20 | 0.43 |
| ▸ | PPARA | Q07869 | 6/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL29226175 | 1.00 | KMT2A (0.48) | KMT2AMAPTCES2CES1HAO1 | |
| Propane SCHEMBL743689 | 1.00 | KMT2A (0.48) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL16061965 | 0.98 | KMT2A (0.50) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL1720049 | 0.98 | KMT2A (0.50) | KMT2AMAPTCES2CES1HAO1 | |
| Hydrochloric Acid SCHEMBL27720432 | 0.96 | KMT2A (0.48) | KMT2AMAPTCES2CES1HAO1 | |
| Propane SCHEMBL28144123 | 0.90 | FAAH (0.57) | KMT2AMAPTPPARGPPARDPPARA | |
| Propane SCHEMBL741627 | 0.90 | FAAH (0.57) | KMT2AMAPTPPARGPPARDPPARA | |
| Propane SCHEMBL26102539 | 0.89 | FAAH (0.55) | KMT2AMAPTPPARGPPARDPPARA | |
| SCHEMBL2905137 | 0.88 | FAAH (0.58) | KMT2AMAPTPPARGPPARDPPARA | |
| Phosphoric Acid SCHEMBL1223979 | 0.83 | FABP3 (0.54) | KMT2AMAPTPPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024148169-A1 | NANOPARTICLE COMPLEXES FOR ENHANCED SAFETY | HDT BIO CORP. (US) | 2024-07-11 | — | — | WO | claimed |
| US-20240216493-A1 | CANCER THERAPY COMPOSITIONS AND USES THEREOF | HDT BIO CORP. | 2024-07-04 | — | — | US | claimed |
| US-20240216274-A1 | DRIED NANOPARTICLE COMPOSITIONS | HDT BIO CORP. | 2024-07-04 | — | — | US | claimed |
| US-20240115728-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | HDT BIO CORP. | 2024-04-11 | — | — | US | claimed |
| WO-2024061356-A1 | INTERFERING RNA FOR INHIBITING TUBB2 GENE EXPRESSION AND USE THEREOF | 北京键凯科技股份有限公司 | 2024-03-28 | — | — | WO | claimed |
| WO-2024061354-A1 | INTERFERING RNA FOR INHIBITING TOP1 GENE EXPRESSION AND USE THEREOF | 北京键凯科技股份有限公司 | 2024-03-28 | — | — | WO | claimed |
| EP-4342929-A1 | POLYETHYLENE GLYCOL LIPID AND USE THEREOF | Jenkem Technology Co. Ltd. (Tianjin) (CN) | 2024-03-27 | — | — | EP | claimed |
| WO-2024052882-A1 | IMMUNOGENIC VACCINE COMPOSITION INCORPORATING A SAPONIN | ACCESS TO ADVANCED HEALTH INSTITUTE (US) | 2024-03-14 | — | — | WO | claimed |
| US-11896677-B2 | Compositions and methods for delivery of RNA | HDT BIO CORP. (US) | 2024-02-13 | — | — | US | claimed |
| WO-2024020453-A2 | IMMUNE SYSTEM MODULATORS AND USES THEREOF | HDT BIO CORP. (US) | 2024-01-25 | — | — | WO | claimed |
| US-20170224616-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2017-08-10 | — | — | US | claimed |
| US-9655845-B2 | Oil-in-water emulsions that contain nucleic acids | GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) | 2017-05-23 | — | — | US | claimed |
| US-20160256541-A1 | Cationic Oil-In-Water Emulsions | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2016-09-08 | — | — | US | claimed |
| US-9295646-B2 | Cationic oil-in-water emulsions | NOVARTIS AG (CH) | 2016-03-29 | — | — | US | claimed |
| US-20140212498-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2014-07-31 | — | — | US | claimed |
| EP-2729125-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | Novartis AG (CH) | 2014-05-14 | — | — | EP | claimed |
| EP-2590625-A2 | CATIONIC OIL-IN-WATER EMULSIONS | Novartis AG (CH) | 2013-05-15 | — | — | EP | claimed |
| WO-2013006834-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | NOVARTIS AG (CH) | 2013-01-10 | — | — | WO | claimed |
| US-20120156251-A1 | CATIONIC OIL-IN-WATER EMULSIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2012-06-21 | — | — | US | claimed |
| WO-2012006380-A2 | CATIONIC OIL-IN-WATER EMULSIONS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | claimed |